Preventing Cancer: The Far-Reaching Impact of Vaccines
For the past 25 years, the global health community has come together each February for World Cancer Day, a time to raise awareness about the impact of cancer and encourage evidence-based prevention strategies. One such strategy is immunization, as certain vaccines have been shown to effectively protect against cancer-causing viruses, including human papillomavirus (HPV) and hepatitis B virus (HBV). These vaccines have the potential to avert and even eliminate some types of cancers, making it all the more critical to ensure that children and adolescents everywhere receive access to these life-saving interventions. |
|
Measles Cases on the Rise
As of February 22, nearly 100 measles cases were reported in Texas and New Mexico. This outbreak demonstrates the importance of maintaining vaccination coverage against this highly contagious disease.
Learn More:
|
|
Public Health On Call: Vaccines 101 Series
 In a new series, the Public Health On Call podcast looks at the basics of vaccines and vaccination, including how they work, the science behind safety, the systems built to ensure children are immunized against life-threatening diseases, and more.
Latest Episodes:
Polio and the Polio Vaccine
In a related episode, IVAC Executive Director Dr. William Moss examines the fear instilled by polio before vaccines and how polio vaccine technology has evolved.
|
|
Decision-Making Considerations & Drivers of Country-Level Adoption to a Single-Dose HPV Vaccination Schedule
In this webinar, HAPPI Consortium partners share the results of their research, offering insights into the critical factors that can shape policy dialogues in other countries regarding HPV vaccine dosing schedules. |
|
Impact of the “Reevaluating and Realigning United States Foreign Aid” Executive Order on Routine Immunization Programs
The Center for Strategic and International Studies (CSIS) Bipartisan Alliance for Global Health Security recently hosted a discussion with Nidhi Bouri, former Deputy Assistant Administrator for Global Health, USAID; Grace Chee, former Director of the MOMENTUM Routine Immunization Transformation and Equity (MRITE); and William Moss, IVAC Executive Director, about the current state of routine immunizations programs and the impacts of the recent executive orders on U.S. foreign assistance and global health. |
|
Global Impact of 10- and 13-Valent Pneumococcal Conjugate Vaccines on Pneumococcal Meningitis in All Ages: The PSERENADE Project [Journal of Infection]
Authors include Yangyupei Yang, Maria Deloria Knoll, Julia Bennett, Maria Garcia Quesada, Marissa Hetrich, Laura Hammitt, Katherine O’Brien, and Kyla Hayford
The authors evaluated long-term direct and indirect effects of PCV10 or PCV13 used in national infant immunization programs on pneumococcal meningitis in all ages globally. They found that following PCV10/PCV13 introduction, pneumococcal meningitis declined in all age groups. |
|
Realist Review of Low- to Upper-Middle-Income Country Experiences on Integration of HPV Vaccination with Other Adolescent Health Services [Vaccine]
By Mary Carol Jennings, Sarah Nabia, Christopher Morgan, Chinelo Cynthia Nduka, Julia Brotherton, Megan Holloway, Katharine Bagshaw, Paul Bloem, and Chizoba Wonodi
Researchers conducted a realist synthesis review to consolidate operational evidence on the benefits of integrating HPV vaccination with other adolescent health services in low- and middle-income countries. They found notable gaps in evidence regarding how an integrated approach might meet unique needs of underserved populations, including out-of-school youth and those affected by HIV. These results can guide future implementation research. |
|
|
|
|
